Atlas Trials

Mesoestetic Pharma Group S.L.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mesoestetic Pharma Group S.L.

RecordFirmDate
Evaluation of the Safety and Performance Characteristics of Mesofiller Mesotox for the Correction of Wrinkles and Rehydration of the Face. (NCT06477432)Mesoestetic Pharma Group S.L.2022-11-15
Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles. (NCT06486740)Mesoestetic Pharma Group S.L.2022-10-03
Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid (NCT05450380)Mesoestetic Pharma Group S.L.2022-08-02
Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds (NCT06482723)Mesoestetic Pharma Group S.L.2022-03-03
Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds (NCT06451822)Mesoestetic Pharma Group S.L.2022-02-03
Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora. (NCT04652817)Mesoestetic Pharma Group S.L.2019-11-11
Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. (NCT04659668)Mesoestetic Pharma Group S.L.2019-11-11
Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation (NCT03537456)Mesoestetic Pharma Group S.L.2018-10-29
Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy (NCT04643977)Mesoestetic Pharma Group S.L.2018-08-30
Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma (NCT02095990)Mesoestetic Pharma Group S.L.2014-03-01

Track Mesoestetic Pharma Group S.L. automatically

Every clearance here is in the API, with alerts when new ones post.